{"date":"2026-08-26","count":28,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2026-08-26-1944-r8ws6k","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"19:44:58","subject":"公告本公司董事會決議以現金增資發行普通股，參與發行美國存託憑證","clause":"第11款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-08-26 19:44，「公告本公司董事會決議以現金增資發行普通股，參與發行美國存託憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-08-26-1856-d8t9b","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"18:56:17","subject":"公告本公司董事會決議召開115年第二次股東臨時會相關事宜","clause":"第17款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-08-26 18:56，「公告本公司董事會決議召開115年第二次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-08-26-1841-37n2dy","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"18:41:32","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-08-26 18:41，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-26-1810-yk53yw","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"18:10:35","subject":"代子公司Norwich Pharmaceuticals, Inc.公告其Rifaximin學名藥藥證申請相關上訴案美國聯邦法院判決結果","clause":"第51款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-26 18:10，「代子公司Norwich Pharmaceuticals, Inc.公告其Rifaximin學名藥藥證申請相關上訴案美國聯」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6431-2026-08-26-1745-sl971k","company_id":"6431","company":"光麗-KY","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"17:45:34","subject":"公告新增背書保證金額達處理準則二十五條第一項第二款之規定辦理","clause":"第22款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：光麗-KY（6431），2026-08-26 17:45，「公告新增背書保證金額達處理準則二十五條第一項第二款之規定辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-08-26-1743-26016j","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"17:43:21","subject":"公告本公司以租地委建方式簽訂興建禾榮科技生醫園區創新大樓之工程合約","clause":"第20款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-08-26 17:43，「公告本公司以租地委建方式簽訂興建禾榮科技生醫園區創新大樓之工程合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6431-2026-08-26-1739-37n2dy","company_id":"6431","company":"光麗-KY","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"17:39:44","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：光麗-KY（6431），2026-08-26 17:39，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-08-26-1735-rgud9t","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"17:35:41","subject":"公告本公司董事會通過115年第二季合併財報","clause":"第31款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-08-26 17:35，「公告本公司董事會通過115年第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-08-26-1734-1qytcve","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"17:34:47","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-08-26 17:34，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-08-26-1734-53q3nc","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"17:34:27","subject":"公告本公司董事會決議庫藏股註銷減資事宜","clause":"第11款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-08-26 17:34，「公告本公司董事會決議庫藏股註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-08-26-1734-140kqs7","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"17:34:04","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-08-26 17:34，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-08-26-1733-1eg7fsl","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"17:33:40","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜","clause":"第23款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-08-26 17:33，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-08-26-1733-1sm5xbj","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"17:33:06","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜","clause":"第23款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-08-26 17:33，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-26-1701-1dumu0","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"17:01:31","subject":"本公司新藥CBL-514注射劑樞紐三期臨床試驗CBL-0301向加拿大HC提出試驗變更案已核准執行。","clause":"第10款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-26 17:01，「本公司新藥CBL-514注射劑樞紐三期臨床試驗CBL-0301向加拿大HC提出試驗變更案已核准執行。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-08-26-1621-1l8i3se","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-08-26","time":"16:21:20","subject":"公告本公司向臺灣證券交易所股份有限公司申請延長股票上市買賣開始期限及完成募集現金增資股款期限","clause":"第44款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-08-26 16:21，「公告本公司向臺灣證券交易所股份有限公司申請延長股票上市買賣開始期限及完成募集現金增資股款期限」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-08-26-1553-qmd25j","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-26","time":"15:53:01","subject":"公告本公司取得簽證會計師內部控制專案審查報告","clause":"第25款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-08-26 15:53，「公告本公司取得簽證會計師內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-08-26-1540-z351id","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"15:40:07","subject":"代子公司全宇工業有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款之規定公告","clause":"第23款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-08-26 15:40，「代子公司全宇工業有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-08-26-1539-kgzzyx","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"15:39:24","subject":"董事會決議不分派半年度股利","clause":"第14款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-08-26 15:39，「董事會決議不分派半年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-08-26-1535-kxgk3x","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-08-26","time":"15:35:11","subject":"公告本公司發言人及代理發言人異動","clause":"第11款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-08-26 15:35，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-08-26-1534-d3vs69","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-08-26","time":"15:34:15","subject":"公告本公司董事會決議設立澳洲子公司","clause":"第44款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-08-26 15:34，「公告本公司董事會決議設立澳洲子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-08-26-1532-6zb90s","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"15:32:00","subject":"公告本公司董事會通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-08-26 15:32，「公告本公司董事會通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-08-26-1529-1hkj5dk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-08-26","time":"15:29:40","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-08-26 15:29，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-08-26-1515-ei7gp4","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-26","time":"15:15:42","subject":"公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得韓國發明專利","clause":"第44款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-08-26 15:15，「公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得韓國發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-08-26-1505-1hkqjpr","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"15:05:35","subject":"代重要子公司太景醫藥研發(北京)有限公司公告監事異動","clause":"第6款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-08-26 15:05，「代重要子公司太景醫藥研發(北京)有限公司公告監事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-08-26-1501-m6y6fe","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"15:01:32","subject":"代重要子公司太景生物科技股份有限公司公告法人代表人董事異動","clause":"第6款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-08-26 15:01，「代重要子公司太景生物科技股份有限公司公告法人代表人董事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-08-26-1438-1bi2fou","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"14:38:30","subject":"本公司受邀參加台新證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-08-27","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-08-26 14:38，「本公司受邀參加台新證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-08-26-1425-145urak","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-08-26","time":"14:25:02","subject":"公告本公司開發治療肺纖維化之挑戰專利學名藥 (P4, Paragraph IV)\"NTN\"取得台灣專利","clause":"第44款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-08-26 14:25，「公告本公司開發治療肺纖維化之挑戰專利學名藥 (P4, Paragraph IV)\"NTN\"取得台灣專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-08-26-1245-1ayroyw","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-08-26","time":"12:45:23","subject":"說明媒體報導內容","clause":"第53款","fact_date":"2026-08-26","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-08-26 12:45，「說明媒體報導內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}